Skip to main content
Equibles
MDXG logo

MDXG · Mimedx Group, Inc.

Track MDXG — free

Use MDXG with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$4.55 +0.03 (+0.66%) At close · Sep 2
Russell 2000 member Rebalance outlook locked
Market Cap
$658.84M
Shares
145.76M

MDXG metrics

75 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$4.55
Market cap
$658.84M

Price action

19 metrics
Price change (1W)
+4.1%
Price change (30D)
+5.9%
Price change (3M)
+26.6%
Price change (6M)
-5.0%
Price change (YTD)
-33.2%
Price change (1Y)
-36.3%
Trailing year
Price change (5Y)
-70.1%
52-week high
$7.96
52-week low
$3.09
Change from 52-week high
-43.2%
Change from 52-week low
+46.3%
Annualized volatility
40.6%
Beta
1.0
RSI (14D)
60.7
Price vs SMA 50
+7.3%
Price vs SMA 200
-4.9%
Avg volume (3M)
1.29M
Relative volume
0.6
Average dollar volume
$5.26M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
145.76M

Valuation

12 metrics
P / E (TTM)
113.0
Trailing earnings · reciprocal yield 0.9%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.9×
reciprocal yield 53.9%
P / book
3.1
reciprocal yield 32.8%
FCF yield
—
TTM · current market cap
Buyback yield
10.4%
P / FCF
—
P / operating cash flow
14.3
reciprocal yield 7.0%
Earnings yield
0.9%

Historical valuation

8 metrics
P / E historical average (3Y)
35.6×
reciprocal yield 2.8%
P / E historical average (5Y)
35.6×
reciprocal yield 2.8%
EV / revenue historical average (3Y)
2.4×
reciprocal yield 41.3%
EV / revenue historical average (5Y)
2.3×
reciprocal yield 42.6%
EV / EBIT historical average (3Y)
24.0×
reciprocal yield 4.2%
EV / EBIT historical average (5Y)
24.0×
reciprocal yield 4.2%
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
10.4%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
78.8%
Operating margin
2.5%
Trailing 12 months
Net margin
1.8%
Gross profit (TTM)
$280.05M
Operating profit (TTM)
$8.75M
Net income (TTM)
$6.24M
Trailing 12 months
Diluted EPS (TTM)
$0.04
FCF margin
—
Effective tax rate
45.9%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$0.67

Growth

11 metrics
Revenue growth YoY
-34.7%
Year over year
Net income growth YoY
-254.3%
Revenue (TTM)
$355.17M
Trailing 12 months
EPS growth YoY
-266.7%
Shares change YoY
-1.0%
Year over year · fewer shares
Revenue CAGR (3Y)
+16.1%
Revenue CAGR (5Y)
+11.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
2.9%
Return on assets
2.2%
Debt / equity
0.1
Current ratio
5.3
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$135.84M
Total assets
$281.00M
Total debt
$17.21M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$46.15M
Capital expenditures (TTM)
$1.99M
R&D (TTM)
$15.38M
SG&A (TTM)
$255.08M
Stock compensation (TTM)
$6.59M
R&D / revenue
4.3%
Stock compensation / revenue
1.9%

Ownership (13F)

3 metrics
13F filers
226
13F filer change QoQ
-13
Institutional ownership
76.8%

Short interest

3 metrics
Short interest
6.1%
Latest settlement · 6.9 days to cover
Days to cover
6.9d
Short-squeeze score
70 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1376339 CUSIP 602496101 13F (30d) 174 filings 174 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)